← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled

CIK 0001438533 #1223 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$39.50M

$10.46M on a plan · $27.53M straight out of an exercise

Sold at will

$1.51M

8 of 86 sales

Net

−$39.50M

−$1.51M against sales at will

By person

16 insiders · 86 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Dube Eric M

CHIEF EXECUTIVE OFFICER

—

$15.95M (13) scheduled

−$15.95M

432,886

0.4592%

$29.47M

+19.6%

REED ELIZABETH E

Chief Legal Officer and GC

—

$4.93M (16) scheduled

−$4.93M

105,211

0.1116%

$7.16M

+31.3%

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

—

$3.86M (5) scheduled

−$3.86M

42,353

0.0449%

$2.88M

−18.6%

ROTE WILLIAM E.

Chief Research Officer

—

$3.29M (4) scheduled

−$3.29M

115,474

0.1225%

$7.86M

+33.0%

Baynes Roy D.

Director

—

$2.55M (6) scheduled

−$2.55M

41,500

0.0440%

$2.83M

+33.9%

Inrig Jula

CHIEF MEDICAL OFFICER

—

$2.37M (11) scheduled

−$2.37M

112,770

0.1196%

$7.68M

+82.0%

Meckler Jeffrey A

Director

—

$1.71M (5) scheduled

−$1.71M

91,500

0.0971%

$6.23M

+13.0%

Cline Christopher R.

CHIEF FINANCIAL OFFICER

—

$1.50M (11) scheduled

−$1.50M

118,016

0.1252%

$8.04M

+58.2%

Coughlin Timothy

Director

—

$1.27M (3) scheduled

−$1.27M

56,250

0.0597%

$3.83M

+14.8%

Heerma Peter

CHIEF COMMERCIAL OFFICER

—

$1.11M (6)

−$1.11M

140,684

0.1492%

$9.58M

+30.3%

LYONS GARY A

Director

—

$961.41K (6) scheduled

−$961.41K

61,500

0.0652%

$4.19M

+20.6%

Squarer Ron

Director

—

39,375

0.0418%

$2.68M

+36.4%

Orwin John A

Director

—

39,375

0.0418%

$2.68M

+36.4%

Poole Sandra

Director

—

34,000

0.0361%

$2.31M

+44.7%

Bruhn Suzanne Louise

Director

—

32,750

0.0347%

$2.23M

+47.2%

Williams Brinkley Ruth

Director

—

29,750

0.0316%

$2.03M

+54.5%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cline Christopher R.

2 Sep 2026

CHIEF FINANCIAL OFFICER

Sell

642

$66.37

$42.61K

Heerma Peter

5 May 2026

CHIEF COMMERCIAL OFFICER

Sell

2,174

$46.65

$101.42K

Heerma Peter

14 Apr 2026

CHIEF COMMERCIAL OFFICER

Sell

7,215

$41.93

$302.52K

REED ELIZABETH E

3 Feb 2026

Chief Legal Officer and GC

Sell

7,175

$32.12

$230.46K

Calvin Sandra

3 Feb 2026

SVP, CHIEF ACCOUNTING OFFICER

Sell

4,333

$32.12

$139.18K

Heerma Peter

3 Feb 2026

CHIEF COMMERCIAL OFFICER

Sell

7,310

$32.12

$234.80K

Cline Christopher R.

3 Feb 2026

CHIEF FINANCIAL OFFICER

Sell

7,242

$32.12

$232.61K

Inrig Jula

3 Feb 2026

CHIEF MEDICAL OFFICER

Sell

6,956

$32.12

$223.43K

Show all 86 transactions →

What was left out

Form 4 filings counted 67

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 37

Sales straight out of an exercise 41

Sales at will 8

Transactions with no price 0

Shares from compensation/vesting 1,207,247

History held since 2 Sep 2016